About The Medical Condition Evaluation Studies, FDA Phase II
Find the definition of the medical term Evaluation Studies, FDA Phase II. Evaluation Studies, FDA Phase II defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Evaluation Studies, FDA Phase II
| Evaluation Studies, FDA Phase II Medical Condition |
|---|
What's The Definition Of The Medical Condition Evaluation Studies, FDA Phase II?
Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Arthroplasties, Replacement, Knee ‐ Replacement of the…
- Soya Oil ‐ Oil from soybean or…
- Tyrosine Aminotransferase ‐ An enzyme that catalyzes the conversion of L-TYROSINE and 2-oxoglutarate…
- Memory Losses, Retrograde ‐ Loss of the ability to recall information that had been previously…
- Deformities, Foot ‐ Alterations or deviations from normal shape or size which result…
- Gas Gangrenes ‐ A severe condition resulting from bacteria invading healthy muscle…
- Neuron, Nitrergic ‐ Nerve cells where transmission is mediated by…
- Teonicol ‐ A vasodilator used in peripheral vascular disorders and insufficiency.…
- Beryllium ‐ Beryllium. An element with the atomic symbol Be, atomic number…
- Hormone Receptors, Nuclear ‐ Proteins in the cytoplasm or nucleus that specifically bind signaling…